EPHA2 and neoplasm: The humanized anti-EphA2 antibody DS-8895a was radiolabeled with [111In], [125I] and [89Zr], but because of its superior imaging and tumor uptake characteristics in breast cancer xenografts, [89Zr]Zr-DS-8895 was chosen as a lead compound.